Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (6): 905-909. doi: 10.3969/j.issn.1671167X.2015.06.003

• Article • Previous Articles     Next Articles

Association between CMTM5 gene rs723840 single nucleotide polymorphism and high on asprin platelet reactivity

LIU Teng-fei, ZHANG Jing-wei, CHEN Xia-huan, FENG Xue-ru, BAI Zhong-sheng, LIU Mei-lin△   

  1. (Department of Geriatrics, Peking University First Hospital, Beijing 100034, China)
  • Online:2015-12-18 Published:2015-12-18
  • Contact: LIU Mei-lin E-mail:meilinliu@yahoo.com
  • Supported by:

    Supported by the International Science & Technology Cooperation Projects of China (2013DFA30860)

Abstract:

Objective: To elucidate the correlation between the single nucleotide polymorphism of CKLF-like MARVEL transmembrane member 5 (CMTM5) gene rs723840 and the occurrence of high on aspirin platelet reactivity (HAPR). Methods:The present study is a case-control study. A total of 210 hospitalized patients in Peking University First Hospital were enrolled. Aspirin response was assessed by 0.5 g/L arachidonic acid (AA)-induced platelet aggregation ratio (PR), and ≥3/4 quartile of PR of the population was defined as HAPR. Accordingly all the enrolled 210 coronary artery diseases (CAD) patients were divided into HAPR group and No-HAPR group. The genotypes were determined by polymerase chain reaction (PCR) and sequencing analysis for rs723840 of CMTM5 gene. Results:The genotype frequencies in rs723840 C>T of CMTM5 gene conformed well to the Hardy-Weinberg equilibrium in both HAPR group and No-HAPR group. Between the two groups, the genotypes frequencies in HAPR and No-HAPR groups were 48.4%, 51.6%, 0.0% and 73.7%, 22.9%, 0.034%, respectively (P=0.004). The C, T allele frequencies were significantly different in the two groups (P=0.031,OR=0.501, 95%CI: 0.264-0.947). Conclusion:Our study finds a significant correlation between CMTM5 gene rs723840 polymorphism and high on aspirin platelet reactivity.

Key words: Platelet aggregation, CMTM5, Polymorphism, single nucleotide, Aspirin

CLC Number: 

  •  
[1] Ming-lu ZHANG,Qiu-ping LIU,Chao GONG,Jia-min WANG,Tian-jing ZHOU,Xiao-fei LIU,Peng SHEN,Hong-bo LIN,Xun TANG,Pei GAO. Comparison of aspirin treatment strategies for primary prevention of cardiovascular diseases: A decision-analytic Markov modelling study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 480-487.
[2] Teng-fei LIU,Tao LIN,Li-hui REN,Guang-ping LI,Jian-jun PENG. Association between CMTM5 gene and coronary artery disease and the relative mechanism [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1082-1087.
[3] Ying CHEN,Zhong-ning LIU,Bo LI,Ting JIANG. Preparation of aspirin sustained-release microsphere and its in vitro releasing [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 907-912.
[4] YANG Rui-li, YU Ting-ting, ZHOU Yan-heng. Acetylsalicylic acid treatment enhanced immunomodulatory function of mesenchymal stem cells derived from gingiva [J]. Journal of Peking University(Health Sciences), 2017, 49(5): 872-877.
[5] DING Fang, LYU Ya-lin, XUAN Wei, LIU Dong-yu, DUAN Xiang-qing, HAN Xiao. Bleeding control of periodontal mechanical therapy for patients taking aspirin [J]. Journal of Peking University(Health Sciences), 2017, 49(1): 49-053.
[6] FENG Xue-ru, LIU Mei-lin, LIU Fang, FAN Yan, TIAN Qing-ping. Dose-response of aspirin on platelet function in very elderly patients [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 835-840.
[7] YANG Cheng, ZHANG Yu-qi, TANG Xun, GAO Pei, WEI Chen-lu, HU Yong-hua. Retrospective cohort study for the impact on readmission of patients with ischemic stroke after treatment of aspirin plus clopidogrel or aspirin mono-therapy [J]. Journal of Peking University(Health Sciences), 2016, 48(3): 442-447.
[8] LIU Teng-fei, ZHANG Jing-wei, CHEN Xia-huan, FENG Xue-ru, BAI Zhong-sheng, LIU Mei-lin. Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabete and coronary artery disease [J]. Journal of Peking University(Health Sciences), 2015, 47(6): 920-924.
[9] YUAN Ye-Qing, ZHANG Yi-Xiang, LIU Zhen-Hua, QIN Cai-Peng, SHENG Zheng-Zuo, XU Tao, WANG Xiao-Feng. Expression and significance of CMTM5 and epidermal growth factor receptor in prostate cancer [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 571-576.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!